New research indicates that individuals who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who end traditional diet and exercise programs.
Research printed in a prominent health publication shows that while overweight individuals frequently drop substantial amounts of their total mass while using the jabs, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.
"Individuals buying such medications need to be aware of the risk of rapid weight regain when the treatment ends," warns researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment weight within about 18 months.
Comparing Treatments
The study, which looked at dozens of trials involving over 9,000 of participants, compared the effects of the injectable medications with older methods.
The team emphasize that people who lose weight through diet and exercise typically experience a less rapid creep back—approximately 100 grams monthly—after stopping.
Explaining the Fast Regain
Nutrition scientists suggest the mechanism of the drugs is key to understanding the accelerated rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication leads to appetite is unsuppressed, making overeating far more likely."
An Ongoing Disease?
The NHS advise the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Many experts contend that, considering the likelihood of relapse, the therapy is often long-term.
This opinion is echoed by pharmaceutical companies, who say that the findings "highlight the chronic nature of obesity," akin to managing conditions like high blood pressure.
User Testimonies
Users who have come off the jabs explain a powerful return of cravings.
"It was like a switch flipping and I was suddenly extremely hungry," said a patient.
This difficulty is worsened if individuals have not established permanent dietary or behavioural changes during treatment.
Growing Adoption
Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest remaining high.
- Adoption is more common among females than men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the medications through private healthcare rather than public health services.
Ultimately, clinicians stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic solution and lasting health benefits likely depends on combined lifestyle support.
